Citation Impact
Citing Papers
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
2009 Standout
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
2014 Standout
OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
2012 Standout
Here, There Be Dragons : Charting Autophagy-Related Alterations in Human Tumors
2012
Transcriptional Regulation by Nrf2
2017 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
p62/SQSTM1 Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene Transcription
2010
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
2016 Standout
Ferroptosis: past, present and future
2020 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
2015 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Nucleocytoplasmic Shuttling of p62/SQSTM1 and Its Role in Recruitment of Nuclear Polyubiquitinated Proteins to Promyelocytic Leukemia Bodies
2009
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
2015 Standout
QuPath: Open source software for digital pathology image analysis
2017 Standout
Regulation of immune cell function and differentiation by the NKG2D receptor
2011
IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer
2015
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Ovarian cancer
2014 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
NRF2 immunolocalization in human breast cancer patients as a prognostic factor
2013
Molecular Breast Cancer Subtypes in Premenopausal African-American Women, Tumor Biologic Factors and Clinical Outcome
2007
Autophagy in mammalian development and differentiation
2010 Standout
The biology and function of fibroblasts in cancer
2016 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
2012
Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism
2016 Standout
SPBP Is a Sulforaphane Induced Transcriptional Coactivator of NRF2 Regulating Expression of the Autophagy Receptor p62/SQSTM1
2014
A meta-analysis of the impact of short-term sleep deprivation on cognitive variables.
2010 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
Significance of immunohistochemistry in breast cancer
2014
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Selective autophagy mediated by autophagic adapter proteins
2011 Standout
Role of Pancreatic Stellate Cells in Pancreatic Cancer Metastasis
2010
The impact of T‐cell immunity on ovarian cancer outcomes
2008
Single Nucleotide Polymorphisms within Interferon Signaling Pathway Genes Are Associated with Colorectal Cancer Susceptibility and Survival
2014
Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology
2017 Standout
Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1
2013
Immunogenic cell death of human ovarian cancer cells induced by cytosolic poly(I:C) leads to myeloid cell maturation and activates NK cells
2011
Autophagy modulation as a potential therapeutic target for diverse diseases
2012 Standout
Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
2009
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
2014 Standout
Metabolic Reprogramming of Stromal Fibroblasts through p62-mTORC1 Signaling Promotes Inflammation and Tumorigenesis
2014
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
2008
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer
2018
p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins
2011
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
2014 Standout
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement
2015 Standout
Digital pathology and artificial intelligence
2019 Standout
Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals
2010 Standout
Inflammation and cancer: how friendly is the relationship for cancer patients?
2009
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Role of Nrf2 in Oxidative Stress and Toxicity
2013 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Accumulation of p62/SQSTM 1 is associated with poor prognosis in patients with lung adenocarcinoma
2012
International Statistical Classification of Diseases and Related Health Problems
2014 Standout
p62/SQSTM 1—Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer
2016
Serum Vascular Endothelial Growth Factor and Fibronectin Predict Clinical Response to High-Dose Interleukin-2 Therapy
2009
Reactive species in non-equilibrium atmospheric-pressure plasmas: Generation, transport, and biological effects
2016 Standout
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer
2016
Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis
2019 Standout
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
2017 Standout
Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer
2011 Standout
Cyclin-Dependent Kinase Inhibitor p27 As a Prognostic Biomarker and Potential Cancer Therapeutic Target
2010
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
2015 Standout
Dual Faces of IFNγ in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity
2016
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Works of Phil Rolland being referenced
Vascular Endothelial Growth Factor Expression in Ovarian Cancer: A Model for Targeted Use of Novel Therapies?
2008
The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive disease
2007
The p53 positive Bcl‐2 negative phenotype is an independent marker of prognosis in breast cancer
2006
ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients
2010
Cytoplasmic p27 Expression is an Independent Prognostic Factor in Ovarian Cancer
2009
Human Leukocyte Antigen Class I Antigen Expression Is an Independent Prognostic Factor in Ovarian Cancer
2007
Loss of IFNγ Receptor Is an Independent Prognostic Factor in Ovarian Cancer
2007